xamoterol has been researched along with epanolol in 3 studies
| Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (epanolol) | Trials (epanolol) | Recent Studies (post-2010) (epanolol) |
|---|---|---|---|---|---|
| 269 | 80 | 17 | 59 | 37 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Halliday, SE; Påby, L; Snow, HM; Vigholt-Sørensen, E | 1 |
| Cuspidi, C; Fruscio, M; Gradnik, R; Leonetti, G; Rupoli, L; Sampieri, L; Terzoli, L; Zanchetti, A | 1 |
1 trial(s) available for xamoterol and epanolol
| Article | Year |
|---|---|
Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Benzeneacetamides; Double-Blind Method; Heart Rate; Humans; Hypertension; Propanolamines; Xamoterol | 1985 |
2 other study(ies) available for xamoterol and epanolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Comparative effects of beta-adrenoceptor partial agonists on isolated rat atrium.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Benzeneacetamides; Heart Atria; Heart Rate; Myocardial Contraction; Prenalterol; Propanolamines; Rats; Stimulation, Chemical; Xamoterol | 1991 |